posted on 2024-11-27, 18:40authored byAleksander Eiken, Sofie Bliddal, Marie Villumsen, Kasper K. Iversen, Henning Bundgaard, Rasmus B. Hasselbach, Jonas H. Kristensen, Pernille B. Nielsen, Mia M. Pries-Heje, Andreas D. Knudsen, Kamille Fogh, Jakob B. Norsk, Ove Andersen, Thea K. Fischer, Ram B. Dessau, Sisse R. Ostrowski, Christian Torp-Pedersen, Sisse B. Ditlev, Mikkel Gybel-Brask, Erik Sørensen, Lene H. Harritshøj, Fredrik Folke, Thomas Benfield, Frederik N. Engsig, Henrik E. Poulsen, Henrik Ullum, Ulla Feldt-Rasmussen, Susanne D. Nielsen, Jørgen Rungby
S1 Table: Antibacterials and chronic disease vs COVID-19 severity. S2 Table: Drugs for obstructive airway disease and chronic disease vs COVID-19 severity. S3 Table: Antibacterials and sex vs COVID-19 severity. S4 Table: Drugs for obstructive airway disease and sex vs COVID-19 severity. S5 Table: Antibacterials and age vs COVID-19 severity. S6 Table: Drugs for obstructive airway disease and age vs COVID-19 severity. S7 Table: Antibacterials and BMI vs COVID-19 severity. S8 Table: Drugs for obstructive airway disease and BMI vs COVID-19 severity. S9 Table: “Any drug” exposure, any chronic disease, age and BMI vs COVID-19 severity.